Clinical trial
Regulation of the Release of Inflammatory Mediators From Lung Macrophages.
NCT00147017 · Imperial College London, Other · Completed
Key facts
| NCT number | NCT00147017 |
|---|---|
| Title | Regulation of the Release of Inflammatory Mediators From Lung Macrophages. |
| Official title | Regulation of the Release of Inflammatory Mediators From Lung Macrophages. |
| Lead sponsor | Imperial College London, Other |
| Collaborators | Novartis Industry Boehringer Ingelheim Royal Brompton & Harefield NHS Foundation Trust |
| Status | Completed |
| Study type | Observational |
| Conditions | COPD, Chronic Bronchitis, Emphysema |
| Enrollment | 17 |
| Start date | Jun 1, 2001 |
| Primary completion | Dec 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Sep 7, 2005 |
| Last update posted | Dec 10, 2019 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: